STOCKSCREENR
Log In

PEN

NYSE

Penumbra, Inc.

$338.00+1.79(+0.53%)Mkt Cap: $13.26B

Key Stats

Market Cap

$13.26B

P/E Ratio

74.94

EPS

$4.51

Dividend Yield

0.00%

52-Week Range

$221.26 — $362.41

Volume

269.29K

Avg Volume

1.00M

Beta

0.84

Valuation

P/E (TTM)

74.94

Forward P/E

66.88

PEG Ratio

9.60

P/S (TTM)

9.46

P/B (TTM)

9.30

P/FCF

235.62

EV/EBITDA

177.61x

EV/Sales

—

Financial Health

ROE (TTM)

0.13%

ROA (TTM)

0.10%

ROIC

0.03%

Gross Margin

0.67%

Operating Margin

0.13%

Net Margin

0.13%

Debt/Equity

0.15

Current Ratio

6.64

Growth

EPS Growth (YoY)

+0.53%

Revenue Growth (YoY)

+0.16%

EPS Growth (3Y)

+14.40%

EPS Growth (5Y)

+8.59%

Sales Growth (3Y)

+0.17%

Sales Growth (5Y)

+0.17%

EPS Est (This Year)

$5.05

EPS Est (Next Year)

$6.44

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

0.00%

Frequency

—

Ex-Dividend Date

—

Cash/Share

$4.77

Analyst Consensus

Price Target Range

$340.00$374.00$388.00
LowMedianHigh

Consensus Target: $369.91(9.4% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

39.23M

Float

37.97M

Free Float %

96.80%

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NYSE

IPO Date

2015-09-18

Employees

4500

CEO

Adam Elsesser

Index Membership

—

Website

https://www.penumbrainc.com

Penumbra, Inc. (PEN) is a healthcare company in the medical - devices industry listed on the NYSE. With a market capitalization of $13.26B, a P/E ratio of 74.94, PEN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PEN against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SNN

Smith & Nephew plc

$33.37

+0.85%

$14.34B

BIO

Bio-Rad Laboratories, Inc.

$269.48

+3.15%

$7.27B

BRKR

Bruker Corporation

$33.74

+2.99%

$5.14B

0YAY.L

Vitrolife AB (publ)

$93.72

+0.86%

$12.69B

0QPY.L

Sonova Holding AG

$188.70

+0.57%

$12.32B

EW

Edwards Lifesciences Corporation

$84.27

+0.85%

$48.94B

Frequently Asked Questions

What is Penumbra, Inc.'s P/E ratio?

Penumbra, Inc. (PEN) has a trailing twelve-month (TTM) P/E ratio of 74.94. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Penumbra, Inc. pay a dividend?

No, Penumbra, Inc. (PEN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Penumbra, Inc.'s market cap?

Penumbra, Inc. (PEN) has a market capitalization of $13.26 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.